Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
P-321 in Dry Eye Disease
NCT02831387Phase 2Terminated
- Sponsor
- Parion Sciences
- Start
- Jul 2016
- Primary completion
- Jun 2017
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of P-321 Ophthalmic Solution placebo in dry eye disease (DED) (2 arms), sponsored by Parion Sciences. Primary endpoint: Change From Baseline to Day 29 in the Subject-reported Dry Eye Symptom Questionnaire. Started Jul 2016; status: terminated.
02
Drugs
P-321 Ophthalmic Solution placebo
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT02831387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02831387.